173 related articles for article (PubMed ID: 19929178)
1. Regulation of p53--insights into a complex process.
Boehme KA; Blattner C
Crit Rev Biochem Mol Biol; 2009; 44(6):367-92. PubMed ID: 19929178
[TBL] [Abstract][Full Text] [Related]
2. Signaling to p53: breaking the posttranslational modification code.
Appella E; Anderson CW
Pathol Biol (Paris); 2000 Apr; 48(3):227-45. PubMed ID: 10858956
[TBL] [Abstract][Full Text] [Related]
3. Regulation of protein Citrullination through p53/PADI4 network in DNA damage response.
Tanikawa C; Ueda K; Nakagawa H; Yoshida N; Nakamura Y; Matsuda K
Cancer Res; 2009 Nov; 69(22):8761-9. PubMed ID: 19843866
[TBL] [Abstract][Full Text] [Related]
4. Regulation of p53 responses by post-translational modifications.
Xu Y
Cell Death Differ; 2003 Apr; 10(4):400-3. PubMed ID: 12719715
[No Abstract] [Full Text] [Related]
5. Differential post-translational modification of the tumour suppressor proteins Rb and p53 modulate the rates of radiation-induced apoptosis in vivo.
Wallace M; Coates PJ; Wright EG; Ball KL
Oncogene; 2001 Jun; 20(28):3597-608. PubMed ID: 11439323
[TBL] [Abstract][Full Text] [Related]
6. The complex interactions of p53 with target DNA: we learn as we go.
Kim E; Deppert W
Biochem Cell Biol; 2003 Jun; 81(3):141-50. PubMed ID: 12897847
[TBL] [Abstract][Full Text] [Related]
7. How important are post-translational modifications in p53 for selectivity in target-gene transcription and tumour suppression?
Olsson A; Manzl C; Strasser A; Villunger A
Cell Death Differ; 2007 Sep; 14(9):1561-75. PubMed ID: 17627286
[TBL] [Abstract][Full Text] [Related]
8. Maintenance of genomic integrity by p53: complementary roles for activated and non-activated p53.
Albrechtsen N; Dornreiter I; Grosse F; Kim E; Wiesmüller L; Deppert W
Oncogene; 1999 Dec; 18(53):7706-17. PubMed ID: 10618711
[TBL] [Abstract][Full Text] [Related]
9. DNA-dependent protein kinase is not required for the p53-dependent response to DNA damage.
Jimenez GS; Bryntesson F; Torres-Arzayus MI; Priestley A; Beeche M; Saito S; Sakaguchi K; Appella E; Jeggo PA; Taccioli GE; Wahl GM; Hubank M
Nature; 1999 Jul; 400(6739):81-3. PubMed ID: 10403253
[TBL] [Abstract][Full Text] [Related]
10. A serine 37 mutation associated with two missense mutations at highly conserved regions of p53 affect pro-apoptotic genes expression in a T-lymphoblastoid drug resistant cell line.
Cinti C; Claudio PP; Luca AD; Cuccurese M; Howard CM; D'Esposito M; Paggi MG; Sala DL; Azzoni L; Halazonetis TD; Giordano A; Maraldi NM
Oncogene; 2000 Oct; 19(44):5098-105. PubMed ID: 11042698
[TBL] [Abstract][Full Text] [Related]
11. Regulation of DNA damage recognition and nucleotide excision repair: another role for p53.
Ford JM
Mutat Res; 2005 Sep; 577(1-2):195-202. PubMed ID: 15927209
[TBL] [Abstract][Full Text] [Related]
12. The role of the E6-p53 interaction in the molecular pathogenesis of HPV.
Thomas M; Pim D; Banks L
Oncogene; 1999 Dec; 18(53):7690-700. PubMed ID: 10618709
[TBL] [Abstract][Full Text] [Related]
13. Methylation-acetylation interplay activates p53 in response to DNA damage.
Ivanov GS; Ivanova T; Kurash J; Ivanov A; Chuikov S; Gizatullin F; Herrera-Medina EM; Rauscher F; Reinberg D; Barlev NA
Mol Cell Biol; 2007 Oct; 27(19):6756-69. PubMed ID: 17646389
[TBL] [Abstract][Full Text] [Related]
14. Post-translational modification of p53 and the integration of stress signals.
Meek DW
Pathol Biol (Paris); 1997 Dec; 45(10):804-14. PubMed ID: 9769944
[TBL] [Abstract][Full Text] [Related]
15. Death squads enlisted by the tumour suppressor p53.
Michalak E; Villunger A; Erlacher M; Strasser A
Biochem Biophys Res Commun; 2005 Jun; 331(3):786-98. PubMed ID: 15865934
[TBL] [Abstract][Full Text] [Related]
16. P53 regulation and function in normal cells and tumors.
Liu Y; Kulesz-Martin M
Medicina (B Aires); 2000; 60 Suppl 2():9-11. PubMed ID: 11188940
[TBL] [Abstract][Full Text] [Related]
17. E2F-1 induces the stabilization of p53 but blocks p53-mediated transactivation.
Nip J; Strom DK; Eischen CM; Cleveland JL; Zambetti GP; Hiebert SW
Oncogene; 2001 Feb; 20(8):910-20. PubMed ID: 11314026
[TBL] [Abstract][Full Text] [Related]
18. p53 regulation by post-translational modification and nuclear retention in response to diverse stresses.
Jimenez GS; Khan SH; Stommel JM; Wahl GM
Oncogene; 1999 Dec; 18(53):7656-65. PubMed ID: 10618705
[TBL] [Abstract][Full Text] [Related]
19. Influence of promoter DNA topology on sequence-specific DNA binding and transactivation by tumor suppressor p53.
Kim E; Rohaly G; Heinrichs S; Gimnopoulos D; Meissner H; Deppert W
Oncogene; 1999 Dec; 18(51):7310-8. PubMed ID: 10602486
[TBL] [Abstract][Full Text] [Related]
20. Target structure-based discovery of small molecules that block human p53 and CREB binding protein association.
Sachchidanand ; Resnick-Silverman L; Yan S; Mutjaba S; Liu WJ; Zeng L; Manfredi JJ; Zhou MM
Chem Biol; 2006 Jan; 13(1):81-90. PubMed ID: 16426974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
